WallStSmart
AKRO

Akero Therapeutics Inc

NASDAQ: AKRO · HEALTHCARE · BIOTECHNOLOGY

$54.65
+0.00% today

Updated 2025-12-09

Market cap
$4.50B
P/E ratio
P/S ratio
EPS (TTM)
$-3.75
Dividend yield
52W range
$32 – $57
Volume
2.9M

Akero Therapeutics Inc (AKRO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+4.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+5.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-4.3%
2025-08-08
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-07$-0.99-6.2%$53.91$54.14+0.4%
2025-08-08$-0.86+4.4%$50.45$48.28-4.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$-0.93$-0.99-6.2%
2025-06-30$-0.90$-0.86+4.4%
2025-03-31$-0.99$-0.90+9.2%
2024-12-31$-1.12$-0.99+11.8%$4000.00-98.6%
2024-09-30$-0.90$-1.05-16.7%
2024-06-30$-0.90$-0.81+10.0%
2024-03-31$-0.95$-0.90+5.3%
2023-12-31$-0.86$-0.99-15.1%$284000.00
2023-09-30$-0.68$-0.71-4.4%
2023-06-30$-0.63$-0.60+4.8%
2023-03-31$-0.67$-0.55+17.9%
2022-12-31$-0.80$-0.49+38.8%

Frequently asked questions

Has Akero Therapeutics Inc beaten earnings estimates?
Akero Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +4.8% over the last 4 quarters.
How does AKRO stock react to earnings?
AKRO stock has moved an average of -1.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.